Published 2002
| Version v1.0.0
Journal Article
Open
Trial of Divalproex for Bipolar Disorder
Creators
Abstract
The safety and effectiveness of divalproex sodium (Depakapote) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadelphia; SUNY Stonybrook, NY; Massachusetts General Hospital, Boston; and University of Texas, San Antonio.Files
PNB-16-74-a.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:187c6ec7c395a89bac752ec960920481
|
1.4 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-16-74-a
Dates
- Created
-
2002When the item was originally created.